Article Details
Retrieved on: 2022-08-31 05:24:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GTB-3650's IND application with the FDA expected by end of first quarter of 2023 GT Biopharma, Inc. (the "Company" or "GTB") GTBP, ...
Article found on: www.einnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here